µå·¯±×ÀÎÆ÷¸ÞÀÎ
 

»óº´Äڵ忡 µû¸¥ »óº´¸íÀ» È®ÀÎ ÇϽǼö ÀÖ½À´Ï´Ù.  
»óº´ÄÚµå ÇÑ±Û»óº´¸í ¿µ¹®»óº´¸í
Y452 Ä¡·á½Ã À¯ÇØÀÛ¿ëÀ» ³ªÅ¸³»´Â ÇÁ·ÎÇǿ»êÀ¯µµÃ¼ Propionic acid derivatives causing adverse effects in therapeutic use
Y452 Ä¡·á½Ã À¯ÇØÀÛ¿ëÀ» ³ªÅ¸³»´Â ÇÁ·ÎÆijë»êÀ¯µµÃ¼ Propanoic acid derivatives causing adverse effects in therapeutic use
Y453 Ä¡·á½Ã À¯ÇØÀÛ¿ëÀ» ³ªÅ¸³»´Â ±âŸ ºñ½ºÅ×·ÎÀ̵åÇ׿°ÁõÁ¦ Other nonsteroidal anti-inflammatory drugs [NSAID] causing adverse effects in therapeutic use
Y454 Ä¡·á½Ã À¯ÇØÀÛ¿ëÀ» ³ªÅ¸³»´Â Ç×·ù¸¶Æ¼½ºÁ¦ Antirheumatics causing adverse effects in therapeutic use
Y455 Ä¡·á½Ã À¯ÇØÀÛ¿ëÀ» ³ªÅ¸³»´Â 4-¾Æ¹Ì³ëÆä³îÀ¯µµÃ¼ 4-Aminophenol derivatives causing adverse effects in therapeutic use
Y458 Ä¡·á½Ã À¯ÇØÀÛ¿ëÀ» ³ªÅ¸³»´Â ±âŸ ÁøÅëÁ¦ ¹× ÇØ¿­Á¦ Other analgesics and antipyretics causing adverse effects in therapeutic use
Y459 Ä¡·á½Ã À¯ÇØÀÛ¿ëÀ» ³ªÅ¸³»´Â »ó¼¼ºÒ¸íÀÇ ÁøÅëÁ¦, ÇØ¿­Á¦ ¹× Ç׿°ÁõÁ¦ Analgesics, antipyretics and anti-inflammatory drug, unspecified causing adverse effects in therapeutic use
Y46 Ä¡·á½Ã À¯ÇØÀÛ¿ëÀ» ³ªÅ¸³»´Â Ç×°£ÁúÁ¦ ¹× Ç×ÆÄŲ½¼Á¦ Antiepileptics and antiparkinsonism drugs causing adverse effects in therapeutic use
Y460 Ä¡·á½Ã À¯ÇØÀÛ¿ëÀ» ³ªÅ¸³»´Â ¼®½Ã´Ï¸¶À̵å Succinimides causing adverse effects in therapeutic use
Y461 Ä¡·á½Ã À¯ÇØÀÛ¿ëÀ» ³ªÅ¸³»´Â ¿Á»çÁ¹¸®µð³×µð¿Â Oxazolidinediones causing adverse effects in therapeutic use
Y462 Ä¡·á½Ã À¯ÇØÀÛ¿ëÀ» ³ªÅ¸³»´Â È÷´ÜÅäÀÎÀ¯µµÃ¼ Hydantoin derivative causing adverse effects in therapeutic use
Y463 Ä¡·á½Ã À¯ÇØÀÛ¿ëÀ» ³ªÅ¸³»´Â µ¥¿Á½Ã¹ÙºñÃò·¹ÀÌÆ® Deoxybarbiturate causing adverse effects in therapeutic use
Y464 Ä¡·á½Ã À¯ÇØÀÛ¿ëÀ» ³ªÅ¸³»´Â À̹̳뽺ƿº¥ Iminostilbenes causing adverse effects in therapeutic use
Y464 Ä¡·á½Ã À¯ÇØÀÛ¿ëÀ» ³ªÅ¸³»´Â Ä«¹Ù¸¶Á¦ÇÉ Carbamazepine causing adverse effects in therapeutic use
Y465 Ä¡·á½Ã À¯ÇØÀÛ¿ëÀ» ³ªÅ¸³»´Â ¹ßǪ·ÎÀÍ »ê Valproic acid causing adverse effects in therapeutic use
Y466 Ä¡·á½Ã À¯ÇØÀÛ¿ëÀ» ³ªÅ¸³»´Â ±âŸ ¹× »ó¼¼ºÒ¸íÀÇ Ç×°£ÁúÁ¦ Other and unspecified antiepileptics causing adverse effects in therapeutic use
Y467 Ä¡·á½Ã À¯ÇØÀÛ¿ëÀ» ³ªÅ¸³»´Â Ç×ÆÄŲ½¼Á¦ Antiparkinsonism drugs causing adverse effects in therapeutic use
Y467 Ä¡·á½Ã À¯ÇØÀÛ¿ëÀ» ³ªÅ¸³»´Â ¾Æ¸¸Å¸µò Amantadin causing adverse effects in therapeutic use
Y468 Ä¡·á½Ã À¯ÇØÀÛ¿ëÀ» ³ªÅ¸³»´Â Ç×°­Á÷Á¦ Antispasticity causing adverse effects in therapeutic use
Y47 Ä¡·á½Ã À¯ÇØÀÛ¿ëÀ» ³ªÅ¸³»´Â ÁøÁ¤Á¦, ¼ö¸éÁ¦ ¹× Ç׺ҾÈÁ¦ Sedatives, hypnotics and antianxiety drugs causing adverse effects in therapeutic use
3871  3872  3873  3874  3875  3876  [3877] 3878  3879  3880